BioCentury
ARTICLE | Clinical News

CT-1501R: Filed an IND

November 1, 1993 8:00 AM UTC

Cell Therapeutics Inc. Product: CT-1501R LPAAT (lysophosphatidate acyltransferase) inhibitor Indication: Prevent and treat septic shock Status: Filed an IND Note: See item in Clinical Results ...